InvestorsHub Logo
icon url

CrashOverride

07/19/23 11:24 PM

#611813 RE: Poor Man - #611807

Robert Hefner agrees with Michael Bigger:

Our Northwest Biotherapeutics (NWBO) investee “partner” likely has just made one of the biggest breakthroughs in the history of cancer. We know that is a really big statement so why do we at GHK believe that is possible? Because we believe the doors through which major cancer breakthroughs must pass are the human immune system, immunotherapies and personalized vaccines and NWBO has just leaped through those doors with its personalized DCVax vaccine made from your own cells.

You can argue about trial statistics until the cows come home but the bottom line is 1) people living longer 2) quality of life during treatments and 3) the cost of treatments.

During NWBO’s 16-year Phase III trial to treat glioblastoma (GBM), one of the most difficult and lethal of all solid tumor cancers 1) more people lived longer, 2) it is safe with virtually no side effects occurring and 3) NWBO estimates treatments will cost about half as much as Standard of Care chemotherapy and radiation treatments. So for the first time ever, GBM patients can have hope! And can hope like prayer increase the effectiveness and energy of the immune system? We think so.

We are aware we stuck our necks out when we said “possibly one of the biggest breakthroughs in the history of cancer”. So we have listed below our three principle reasons so you can decide for yourself:

After 417 failed GBM trials treating 31,952 patents over decades, DCVax-L is first treatment that gives GBM patients a meaningful chance to live longer, some now living 9 to as many as 19 years and counting.

DCVax was conceived and created not for glioblastoma alone but as a personalized tool of your own immune system to defeat all solid tumor cancers and that’s 90% of all cancers.

Since DCVax’s creation NWBO has amassed an enormous rich databank containing masses of information on patients, treatments, and DCVax’s use against 15 different solid tumor cancers that has not yet been analyzed by artificial intelligence (AI). We believe that in the near future when these vast amounts of data and information are teamed with AI and some of the world’s leading scientists and doctors that future generations of DCVax vaccines and protocols will experience great leaps forward in effectiveness at lower and lower costs for 90% of all cancers.

So to sum up, we believe NWBO with its DCVax immunotherapy personalized vaccines has leaped through the doors and will play a vital role in humanities great drive to defeat cancer once and for all.




https://ghkco.com/wp-content/uploads/2022/06/2022-06-07_Statement-by-Robert-Hefner-on-NWBOs-DCVax-L-Phase-III-Trial.pdf



Robert Hefner lobbied Carter and Congress to deregulate the natural gas industry in the 1970s. He invented a method of drilling extremely deep natural gas wells. His company went bust in the early 1980s though he took his knowledge to China developing natural gas drilling in that country. He 87 now so invests his money from a family office. His representative, Wade Kovash, was at ASCO.

http://johnsedgwick.biz/pdf/Success!_TheManWhoLost700MillionFullWeb.pdf













Hefner with Les Goldman In 2011:



Some focus on irrational munande details.  Others remain focused on the big picture.

Some things take time.   You can't make a child in one month by getting nine women pregnant!
Bullish
Bullish
icon url

supersteve13

07/20/23 12:44 AM

#611830 RE: Poor Man - #611807

Interesting that you left out his “of course” response to the question of if he’s bullish. :)
In fact, you closely/ awkwardly cropped that Twitter pic in order to exclude that part. :)

You’re 100% full of shit, eh?
icon url

biosectinvestor

07/20/23 8:14 AM

#611852 RE: Poor Man - #611807

That’s not the meaning of his exchange. You did not post the link to the full exchange but a picture of it so you can spin it anyway you want. And people answering after also spun it. There is absolutely nothing there implying the negativity you suggest. He simply has some ideas he would like to discuss, ideas which are very similar to ideas I have discussed here at length, though there may be contrary views about whether the company should share the insights and data it can reap from its tissue and cancer antigen/genetic database which will be unique in the history of oncology companies.

You’re claim is baseless.



icon url

QL300

07/20/23 8:49 AM

#611877 RE: Poor Man - #611807

If you look at the first part, 3 questions were asked:

Are you still bullish?

Have you spoken with management and are you concerned?

Is it all in due time?

His response was “of course”. You have a 1/3 chance of his response responding to the 2nd question and him being concerned. However, when multiple questions are being asked and only one response is given, people are usually responding to the first question or the last question. Not a question in the middle.

His 2nd response is “so much potential”. Why can’t that be in response to “we are on the cusp of something great here”? That would make the most sense.

Also, his initial tweet is qualified with “if required.”

Nothing here points to any issue with management. You can read into it all you want. He is waiting for MAA submission like the rest of us.
icon url

kabunushi

07/20/23 11:16 AM

#611956 RE: Poor Man - #611807

But you're not at all attempting to put words in Bigger’s mouth when you say 'with the silent part being “but it’s not being realized.”'? I guess the irony in that is lost on you, LOL.